Federated Hermes, Inc. Repligen Corp Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 321,821 shares of RGEN stock, worth $50.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

321,821

Previous 321,402 0.13%

Holding current value

$50.9 Million

Previous $40.5 Million 18.21%

% of portfolio

0.11%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$119.79 - $167.35 $50,192 - $70,119	419 Added 0.13%	321,821 $47.9 Million
Q2 2024 Aug 08, 2024	SELL	$120.0 - $182.95 $21,960 - $33,479	-183 Reduced 0.06%	321,402 $40.5 Million
Q1 2024 May 14, 2024	SELL	$170.78 - $208.42 $12.8 Million - $15.6 Million	-74,983 Reduced 18.91%	321,585 $59.1 Million
Q4 2023 Jan 31, 2024	SELL	$114.17 - $185.35 $5.63 Million - $9.14 Million	-49,325 Reduced 11.06%	396,568 $71.3 Million
Q3 2023 Nov 13, 2023	SELL	$138.78 - $176.51 $636,167 - $809,121	-4,584 Reduced 1.02%	445,893 $70.9 Million
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $25,469 - $33,177	-184 Reduced 0.04%	450,477 $63.7 Million
Q1 2023 May 08, 2023	SELL	$154.26 - $198.1 $8.6 Million - $11 Million	-55,746 Reduced 11.01%	450,661 $75.9 Million
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $559,536 - $759,829	3,445 Added 0.68%	506,407 $85.7 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $1.92 Million - $3.07 Million	-11,982 Reduced 2.33%	502,962 $94.1 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $4.66 Million - $6.22 Million	-33,096 Reduced 6.04%	514,944 $83.6 Million
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $2.39 Million - $3.83 Million	-14,852 Reduced 2.64%	548,040 $103 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $138,155 - $169,894	-558 Reduced 0.1%	562,892 $149 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $200,223 - $333,287	-1,028 Reduced 0.18%	563,450 $163 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $12.7 Million - $16.9 Million	-76,320 Reduced 11.91%	564,478 $113 Million
Q1 2021 May 13, 2021	SELL	$180.37 - $226.26 $8.86 Million - $11.1 Million	-49,147 Reduced 7.12%	640,798 $125 Million
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $1.49 Million - $2.08 Million	10,072 Added 1.48%	689,945 $132 Million
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $545,414 - $704,618	-4,452 Reduced 0.65%	679,873 $100 Million
Q2 2020 Aug 13, 2020	BUY	$94.33 - $140.48 $4.38 Million - $6.53 Million	46,449 Added 7.28%	684,325 $84.6 Million
Q1 2020 May 13, 2020	SELL	$84.96 - $109.14 $38.1 Million - $48.9 Million	-448,354 Reduced 41.28%	637,876 $61.6 Million
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $3.99 Million - $5.03 Million	-54,093 Reduced 4.74%	1,086,230 $100 Million
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $11.2 Million - $14 Million	146,354 Added 14.72%	1,140,323 $87.5 Million
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $2.36 Million - $3.74 Million	43,555 Added 4.58%	993,969 $85.4 Million
Q1 2019 May 10, 2019	BUY	$49.45 - $62.8 $427,297 - $542,654	8,641 Added 0.92%	950,414 $56.2 Million
Q4 2018 Feb 13, 2019	BUY	$48.26 - $68.88 $11.8 Million - $16.9 Million	245,493 Added 35.26%	941,773 $49.7 Million
Q3 2018 Nov 13, 2018	SELL	$46.8 - $58.97 $5.52 Million - $6.96 Million	-117,958 Reduced 14.49%	696,280 $38.6 Million
Q2 2018 Aug 10, 2018	SELL	$35.26 - $47.04 $4.12 Million - $5.49 Million	-116,718 Reduced 12.54%	814,238 $38.3 Million
Q1 2018 May 09, 2018	BUY	$30.92 - $37.27 $2.18 Million - $2.62 Million	70,396 Added 8.18%	930,956 $33.7 Million
Q4 2017 Feb 14, 2018	BUY	$32.53 - $38.92 $860,841 - $1.03 Million	26,463 Added 3.17%	860,560 $0
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $30.8 Million - $38.4 Million	834,097	834,097 $32 Million

Others Institutions Holding RGEN

# of Institutions

489

Shares Held

54.3M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.78B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Repligen Corp Transaction History